The effects of alpha-lipoic acid on MMP-2 and MMP-9 activities in a rat renal ischemia and re-perfusion model

Biotechnic and Histochemistry

Volumn 89, Issue 4, 2014, Pages 304-314

  Cavdar, Z ^a   Ozbal, S ^b   Celik, A ^c   Ergur, B U ^b   Guneli, E ^c   Ural, C ^a   Camsari, T ^b   Guner, G A ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b Faculty of Dental Sciences   (India)

^c Department of Laboratory Animal Science Health Sciences Institute   (United States)

Author keywords

Ischemia; Kidney; Lipoic acid; MMP 2; MMP 9; Oxidative stress; Re perfusion; TIMP 1; TIMP 2

Indexed keywords

ANTIOXIDANT; GELATINASE A; GELATINASE B; MMP2 PROTEIN, RAT; MMP9 PROTEIN, RAT; THIOCTIC ACID;

ANIMAL; DRUG EFFECTS; ENZYME ACTIVATION; ENZYMOLOGY; KIDNEY; MALE; METABOLISM; PATHOLOGY; RAT; REPERFUSION INJURY; TISSUE DISTRIBUTION; TREATMENT OUTCOME; VASCULARIZATION; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; ENZYME ACTIVATION; KIDNEY; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; RATS; RATS, WISTAR; REPERFUSION INJURY; THIOCTIC ACID; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

EID: 84903897162     PISSN: 10520295     EISSN: 14737760     Source Type: Journal    
DOI: 10.3109/10520295.2013.847498     Document Type: Article

References (36)

1. Bae EH, Lee KS, Lee J, Ma SK, Kim NH, Choi KC, Frøkiaer J, Nielsen S, Kim SY, Kim SZ, Kim SH, Kim SW (2008) Effects of alpha-lipoic acid on ischemia-re-perfusion-induced renal dysfunction in rats. Am. J. Physiol. Renal Physiol. 294: F272-F280.
2. Basile DP, Fredrich K, Weihrauch D, Hattan N, Chilian WM (2004) Angiostatin and matrix metallopro-tease expression following ischemic acute renal failure. Am. J. Physiol. Renal Physiol. 286: F893-F902.
3. Bogani P, Canavesi M, Hagen TM, Visioli F, Bellosta S (2007) Thiol supplementation inhibits metalloproteinase activity independent of glutathione status. Biochem. Biophys Res. Commun. 363: 651-655.
4. Bosman F, Stamenkovic I (2003) Functional structure and composition of the extracellular matrix. J. Pathol. 200: 423-428.
5. Caron A, Desrosiers RR, Béliveau R (2005a) Ischemia injury alters endothelial cell properties of kidney cortex: stimulation of MMP-9. Exp. Cell Res. 310: 105-116.
6. Caron A, Desrosiers RR, Langlois S, Béliveau R (2005b) Ischemia-re-perfusion injury stimulates gelatinase expression and activity in kidney glomeruli. Can. J. Physiol. Pharmacol. 83: 287-300.
7. Cavdar Z, Egrilmez MY, Bulbul M, Guner G, Kocturk S (2006) Quantitation of total and reduced glutathione in erythrocyte by high performance liquid chromatography. Turk. J. Biochem. 31: 187-193.
8. Cereser C, Guichard J, Drai J, Bannier E, Garcia I, Boget S, Parvaz P, Revol A (2001) Quantitation of reduced and total glutathione at the femtomole level by high-performance liquid chromatography with fluores-cence detection: application to red blood cells and cultured fbroblasts. J. Chromatogr. B Biomed. Sci. Appl. 752: 123-132.
9. Clark IM, Swingler TE, Sampieri CL, Edwards DR (2008) The regulation of matrix metalloproteinases and their inhibitors. Int. J. Biochem. Cell Biol. 40: 1362-1378.
10. de Groot H, Rauen U (2007) Ischemia-re-perfusion injury: processes in pathogenetic networks: a review. Transplant Proc. 39: 481-484.
11. Dejonckheere E, Vandenbroucke RE, Libert C (2011) Matrix metalloproteinases as drug targets in ischemia/re-perfusion injury. Drug Discov. Today 16: 762-778.
12. Goraca A, Huk-Kolega H, Piechota A, Kleniewska P, Ciejka E, Skibska B (2011) Lipoic acid-biological activity and therapeutic potential. Pharmacol. Rep. 63: 849-858.
13. Iimura O, Takahashi H, Yashiro T, Madoiwa S, Sakata Y, Asano Y, Kusano E (2004) Effect of ureteral obstruction on matrix metalloproteinase-2 in rat renal cortex. Clin. Exp. Nephrol. 8: 223-229.
14. Kaneko T, Shimizu A, Mii A, Fujita E, Fujino T, Kunugi S, Du X, Akimoto T, Tsuruoka S, Ohashi R, Masuda Y, Iino Y, Katayama Y, Fukuda Y (2012) Role of matrix metalloproteinase-2 in recovery after tubular damage in acute kidney injury in mice. Nephron Exp. Nephrol. 122: 23-35.
15. Kennedy SE, Erlich JH (2008) Murine renal ischaemia-re-perfusion injury. Nephrology 13: 390-396.
16. Kim HS, Kim HJ, Park KG, Kim YN, Kwon TK, Park JY, Lee KU, Kim JG, Lee IK (2007) Alpha-lipoic acid inhibits matrix metalloproteinase-9 expression by inhibiting NF-kappa B transcriptional activity. Exp. Mol. Med. 39: 106-113.
17. Kleiner DE, Stetler-Stevenson WG (1994). Quantitative zymography: detection of picogram quantities of gelati-nases. Anal. Biochem. 218: 325-329.
18. Kumral A, Tuzun F, Ozbal S, Ugur Ergur B, Yilmaz O, Duman N, Ozkan H (2012) Lipopolysaccharide-preconditioning protects against endotoxin-induced white matter injury in the neonatal rat brain. Brain Res. 1489: 81-89.
19. Kunugi S, Shimizu A, Kuwahara N, Du X, Takahashi M, Terasaki Y, Fujita E, Mii A, Nagasaka S, Akimoto T, Masuda Y, Fukuda Y (2011) Inhibition of matrix metalloproteinases reduces ischemia-re-perfusion acute kidney injury. Lab. Invest. 91: 170-180.
20. Lee HS, Na MH, Kim WK (2010) Alpha-lipoic acid reduces matrix metalloproteinase activity in MDA-MB-231 human breast cancer cells. Nutr. Res. 30: 403-409.
21. Lee SY, Hörbelt M, Mang HE, Knipe NL, Bacallao RL, Sado Y, Sutton TA (2011) MMP-9 gene deletion mitigates microvascular loss in a model of ischemic acute kidney injury. Am. J. Physiol. Renal Physiol. 301: F101-F109.
22. Lykkesfeldt J (2001) Determination of malondialdehyde as dithiobarbituric acid adduct in biological samples by HPLC with fluorescence detection: comparison with ultraviolet-visible spectrophotometry. Clin. Chem. 47: 1725-1727.
23. Micili SC, Ergur BU, Ozogul C, Sarioglu S, Bagriyanik HA, Tugyan K, Pekcetin C, Sonmez U, Tekmen I, Erbil G, Akdogan GG, Ozyurt D, Buldan Z (2012) Effects of lipoic acid in an experimentally i nduced hypertensive and diabetic rat model. Clin. Exp. Hypertens. doi: 10.3109/10641963.2012.732647: 1-9.
24. Nagase H, Visse R, Murphy G (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc. Res. 69: 562-573.
25. Novak KB, Le HD, Christison-Lagay ER, Nose V, Doiron RJ, Moses MA, Puder M (2010) Effects of metalloproteinase inhibition in a murine model of renal ischemia-re-perfusion injury. Pediatr. Res. 67: 257-262.
26. Ozbal S, Ergur BU, Erbil G, Tekmen I, Bagriyanik A, Cavdar Z (2012) The effects of α-lipoic acid against tes-ticular ischemia-reperfusion injury in rats. Sci. World J. 10.1100/2012/489248: 1-8.
27. Reel B, Guzeloglu M, Bagriyanik A, Atmaca S, Aykut K, Albayrak G, Hazan E (2013) The effects of PPAR-γ agonist pioglitazone on renal ischemia/re-perfusion injury in rats. J. Surg. Res. 182: 176-184.
28. Sehirli O, Sener E, Cetinel S, Yüksel M, Gedik N, Sener G (2008) Alpha-lipoic acid protects against renal ischaemia-re-perfusion injury in rats. Clin. Exp. Pharmacol Physiol. 35: 249-255.
29. Sutton TA, Kelly KJ, Mang HE, Plotkin Z, Sandoval RM, Dagher PC (2005) Minocycline reduces renal micro-vascular leakage in a rat model of ischemic renal injury. Am. J. Physiol. Renal Physiol. 2288: F91-F97.
30. Takaoka M, Ohkita M, Kobayashi Y, Yuba M, Matsumura Y (2002) Protective effect of alpha-lipoic acid against ischaemic acute renal failure in rats. Clin. Exp. Pharmacol. Physiol. 29: 189-194.
31. Takayama J, Takaoka M, Sugino Y, Yamamoto Y, Ohkita M, Matsumura Y (2007) Sex difference in ischemic acute renal failure in rats: approach by proteomic analysis. Biol. Pharm. Bull. 30: 1905-1912.
32. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39: 44-84.
33. Wang X, Yu Y, Ji L, Liang X, Zhang T, Hai CX (2011) Alpha-lipoic acid protects against myocardial ischemia/re-perfusion injury via multiple target effects. Food Chem. Toxicol. 49: 2750-2757
34. Weight SC, Bell PR, Nicholson ML (1996) Renal ischaemia-re-perfusion injury. Br. J. Surg. 83: 162-170.
35. Wiechelman KJ, Braun RD, Fitzpatrek JD (1988) Investigation of bicinchoninic acid protein assay: iden-tif cation of the groups responsible for color formation. Anal. Biochem. 175: 231-237.
36. Yasuda H, Yuen PS, Hu X, Zhou H and Star RA (2006) Simvastatin improves sepsisinduced mortality and acute kidney injury via renal vascular effects. Kidney Int. 69: 15351542.